Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026

2 days ago 3

Noor Ul Ain Rehman

Thu, May 14, 2026 astatine 11:51 AM CDT 2 min read

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is 1 of the champion tiny headdress stocks to bargain for 10x potential. Taysha Gene Therapies, Inc. (NASDAQ:TSHA) announced fiscal results for fiscal Q1 2026 connected May 6, reporting that it reaffirmed U.S. Food and Drug Administration (FDA) alignment connected the planned pathway to a Biologics License Application (BLA) submission for TSHA-102. This came aft a caller archetypal breakthrough therapy Type B multidisciplinary gathering with the FDA and includes pivotal proceedings plan and endpoints, and BLA submission scenarios, including the imaginable to taxable for support based connected the six-month interim investigation from the REVEAL pivotal trial.

REGN) the Best Bet successful Gene Therapy Industry?

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) besides reported that it further precocious dosing successful the REVEAL pivotal trial, with aggregate patients dosed crossed respective objective proceedings sites. Furthermore, enrollment successful the ASPIRE proceedings is ongoing crossed respective objective proceedings sites, and TSHA-102 is continuing to beryllium mostly well-tolerated. Taysha Gene Therapies, Inc. (NASDAQ:TSHA) besides initiated a BLA-enabling PPQ run for TSHA-102 utilizing a commercialized manufacturing process successful April 2026.

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is simply a clinical-stage biotechnology institution that develops and commercializes adeno-associated microorganism (AAV) based cistron therapies to dainty monogenic diseases of the cardinal tense system. The institution is besides progressive successful the improvement of aggregate cistron therapy platforms, including AAV9 Discovery, Novel Capsid, and AAV Redosing.

While we admit the imaginable of TSHA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article